Sweden· SE-20230222000029
Fesoterodine 2care4 4 mg Depottablett
A fesoterodine product, registered in Sweden by 2care4 ApS. The same ATC class is registered in 18 of our 19 countries.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
Where it is registered
Fesoterodine is registered in 18 of 19 countries.
Countries holding a registration under ATC G04BD11 (fesoterodine), each read from that country’s own register.
- This record: Sweden, from Swedish Medical Products Agency (Sweden)
- 11 of them publish a price we can compare per daily dose
Fesoterodine · ATC G04BD11
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of fesoterodine costs, country by country.
Normalised to the WHO defined daily dose (4 mg), the median price runs from $0.19 in France to $1.14 in Switzerland — a ×6.0 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Fesoterodine · price per daily dose (4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.14
- ES Spain$0.73
- IT Italy$0.32
- FR France$0.19
The record
At a glance
Swedish Medical Products Agency (Sweden)- Manufacturer
- 2care4 ApS
- Country
- Sweden (SE)
- ATC code
- G04BD11
- ATC class
- Fesoterodine
- Defined daily dose
- 4 mg, O
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20230222000029
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
191 interactions on record for fesoterodine.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fesoterodine · interactions on record
191 records
- 9 severe
- 141 moderate
Most severe, free to view
- KetoconazoleH02CA03severe
- ClarithromycinJ01FA09severe
- KetoconazoleJ02AB02severe
- Darunavir and cobicistatJ05AR14severe
41 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under G04BD11
Fesoterodine, as other registers publish it.
- DenmarkFesoterodin "Accord"Accord Healthcare B.V.
- DenmarkFesoterodin "Accord"Accord Healthcare B.V.
- NorwayFesoterodin AccordAccord Healthcare B.V.
- NorwayFesoterodin AccordAccord Healthcare B.V.
- GermanyFesoterodin AlAliud Pharma Gmbh
- GermanyFesoterodin AlAliud Pharma Gmbh
- NorwayFesoterodin aristoAristo Pharma
- NorwayFesoterodin aristoAristo Pharma
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4f84a674-04b4-4bc0-b489-0a619451f7a1 GET /v1/drugs/4f84a674-04b4-4bc0-b489-0a619451f7a1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL"
],
"se_npl_id": "20230222000029",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20230222000029",
"product_doc_link": "https://docetp.mpa.se/LMF/Fesoterodine%202care4%204%20mg%20prolonged-release%20tablet%20ES%20PL_09001bee835ac89a.pdf"
}See everything about fesoterodine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.